Success Metrics

Clinical Success Rate

100.0%

Based on 1 completed trials

Completion Rate

100%(1/1)

Active Trials

1(33%)

Results Posted

100%(1 trials)

Phase Distribution

Ph phase_2

33%

Ph not_applicable

67%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 2Efficacy & side effects

1(33.3%)

N/ANon-phased studies

2(66.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(1)

Detailed Status

Enrolling by invitation1

Completed1

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 21 (33.3%)

N/A2 (66.7%)

Trials by Status

enrolling_by_invitation133%

completed133%

recruiting133%

Recent Activity

1 active trials

Showing 3 of 3

enrolling_by_invitationnot_applicable

A Pilot Study on the Efficacy of 2% Cholesterol Cream in Preventing Transepidermal Water Loss and Clinical Symptoms in Mild to Moderate Atopic Dermatitis

NCT07503197

recruitingphase_2

Topical Ketotifen 0.25% for Secondary Vestibulodynia

NCT07257029

completednot_applicable

Topical Centella Asiatica and the Cosmetic Appearance of Stretch Marks

NCT02601105

Clinical Trials (3)

Showing 3 of 3 trials

NCT07503197Not Applicable

A Pilot Study on the Efficacy of 2% Cholesterol Cream in Preventing Transepidermal Water Loss and Clinical Symptoms in Mild to Moderate Atopic Dermatitis

Enrolling By Invitation

NCT07257029Phase 2

Topical Ketotifen 0.25% for Secondary Vestibulodynia

Recruiting

NCT02601105Not Applicable

Topical Centella Asiatica and the Cosmetic Appearance of Stretch Marks

Completed

All 3 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 3